Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection
Completed · Not applicable
Conditions studied: Infertility, Infertility, Male
In brief
Laser-assisted intracytoplasmic sperm injection (ICSI) has been suggested as a more effective alterative to conventional ICSI when this method of insemination is indicated for patients undergoing in vitro fertilization (IVF). Laser-assisted ICSI differs from conventional ICSI in that a laser is used to drill a small hole through the hard outer coating surrounding an egg before the injection needle containing a single sperm is inserted into the egg. The hole eliminates compression of the egg that normally occurs with conventional ICSI, and thus may reduce the chance of damage. Laser-assisted ICSI is hypothesized to result in increased egg survival, and perhaps improved embryo quality, compared to conventional ICSI.
Key facts
- Study ID
- NCT00114725
- Run by
- Shady Grove Fertility Reproductive Science Center
- People needed
- 60
- Starts
- 2004-03-01
- Expected to finish
- 2004-10-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of infertility
- Scheduled for IVF with ICSI
You may not qualify if…
- Retrieval of fewer than 6 mature oocytes
Where it is running
- Shady Grove Fertility Reproductive Science Center — Rockville, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.